Furthermore, trends for increase of incidences of malignant lymphomas/leukemias induced by the DMBDD treatment in Ogg1−/− mice as compared to the Ogg1−/− controls and DMBDD-treated Ogg1+/+ animals were found. This evidence concerns the gene OGG1 and leukemia.